3-D Matrix, North America, based in Newton, Massachusetts, is a wholly owned subsidiary of 3-D Matrix, Ltd., Tokyo, Japan. The 3-D Matrix Group develops and manufactures a family of peptide biomaterials under the trade name PuraMatrix® for use in clinical applications and life science research. 3-D Matrix has driven development of its technology leveraging the activities of its founding scientists at MIT. 3-D Matrix, North America received FDA 510k clearance for PuraSinus™ in April, 2019. For more information, contact us: [email protected]